Please login to view this media
- Talk
- Canada
Genes Related to Muscle Strength, Behavioral Trait, Pain Response, and Inflammation are Associated with Poor Outcome of the Total Joint Replacement Therapy in Primary Osteoarthritis Patients
Description
The speaker, Salem Werdyani, presents a study on the genetic factors associated with poor outcomes in total joint replacement surgeries for patients with end-stage osteoarthritis. The discussion begins by emphasizing the significance of this therapy, noting that about 22% of patients fail to improve or show deterioration after surgery. The project utilizes Genome-Wide Association Studies (GWAS) to identify genetic variants linked to these poor outcomes.
The study analyzed 104 patients who underwent total joint replacement due to hip or knee osteoarthritis, utilizing the Western Ontario and McMaster University Osteoarthritis Index to assess pain and functional impairment before and up to four years after surgery. Patients failing to achieve a certain score improvement were classified as nonresponders.
DNA samples from these patients were processed and genotyped using a high-density SNP genotyping array, followed by quality controls. The genotyping data were imputed to enhance the accuracy of the genetic analysis.
The results revealed specific chromosomal regions, notably on chromosomes one, five, seven, and eight, associated with pain nonresponders. Key SNPs identified include those linked to genes involved in neurotransmission, muscle strength, behavioral functions, and pain response.
Further analysis extended to chromosomes one, two, and ten, which were significantly associated with nonresponders in functional outcomes. The identified genetic variants suggest a complex interplay between inflammation, obesity, and genetic predisposition affecting recovery following joint replacement.
In conclusion, this pioneering research underscores the molecular factors contributing to diminished outcomes post-surgery and opens avenues for better patient stratification and personalized treatment strategies. Werdyani acknowledges the contributions of the research team, study participants, and funding bodies, closing with gratitude for the audience's attention.